Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (511-520 of 692) with videos related to

Pageof 70
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III studyB Biesma, A N M Wymenga, A Vincent, et al.
Plos One|March 6, 2008
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential targetMariëlle I Gallegos Ruiz, Karijn Floor, Paul Roepman, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trialBen J Slotman, Corinne Faivre-Finn, Harm van Tinteren, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2007
The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epitheliumRemco M van den Berg, Harm van Tinteren, Nico van Zandwijk, et al.
Immuno-Oncology Technology|August 26, 2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapyM Yeghaian, Z Bodalal, T M Tareco Bucho, et al.
British Journal of Cancer|May 15, 2024
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancerUmberto Malapelle, Natasha Leighl, Alfredo Addeo, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2015
Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial LesionsRobert A A van Boerdonk, Illaa Smesseim, Daniëlle A M Heideman, et al.
British Journal of Cancer|April 19, 2014
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trialD E Ediebah, C Coens, E Zikos, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2009
[Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]S Y El Sharouni, J G J V Aerts, S Senan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Pageof 70

Showing results (511-520 of 692) with videos related to

Sort By:
Pageof 70
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III studyB Biesma, A N M Wymenga, A Vincent, et al.
Plos One|March 6, 2008
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential targetMariëlle I Gallegos Ruiz, Karijn Floor, Paul Roepman, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trialBen J Slotman, Corinne Faivre-Finn, Harm van Tinteren, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2007
The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epitheliumRemco M van den Berg, Harm van Tinteren, Nico van Zandwijk, et al.
Immuno-Oncology Technology|August 26, 2024
Integrated noninvasive diagnostics for prediction of survival in immunotherapyM Yeghaian, Z Bodalal, T M Tareco Bucho, et al.
British Journal of Cancer|May 15, 2024
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancerUmberto Malapelle, Natasha Leighl, Alfredo Addeo, et al.
American Journal of Respiratory and Critical Care Medicine|August 15, 2015
Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial LesionsRobert A A van Boerdonk, Illaa Smesseim, Daniëlle A M Heideman, et al.
British Journal of Cancer|April 19, 2014
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trialD E Ediebah, C Coens, E Zikos, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2009
[Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]S Y El Sharouni, J G J V Aerts, S Senan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Pageof 70